Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 2Phase 2 1

Status

Completed 3Active not recruiting 2Terminated 1

Sponsor Class

OTHER 27INDUSTRY 6FED 1

Study Type

Interventional 6Observational 3

Sponsor

Conditions

Neoplasms 2875Carcinoma, Non-Small-Cell Lung 2428Breast Neoplasms 2068Colorectal Neoplasms 1247Neoplasm Metastasis 1232Prostatic Neoplasms 1080Melanoma 974Multiple Myeloma 963Ovarian Neoplasms 904Recurrence 852Leukemia, Myeloid, Acute 810Lung Neoplasms 758Pancreatic Neoplasms 753Lymphoma, Non-Hodgkin 727Lymphoma 660Stomach Neoplasms 623Carcinoma, Hepatocellular 566Carcinoma, Renal Cell 546Squamous Cell Carcinoma of Head and Neck 529Leukemia, Lymphocytic, Chronic, B-Cell 493Lymphoma, Follicular 468Head and Neck Neoplasms 451Glioblastoma 436Advanced Solid Tumors 432Small Cell Lung Carcinoma 411Triple Negative Breast Neoplasms 410Lymphoma, Large B-Cell, Diffuse 398Leukemia 394Uterine Cervical Neoplasms 369Advanced Solid Tumor 351

Interventions

Therapeutics 1Ralfinamide 1Lidoderm 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × Neuroma × Clear all
NCT04865679 2026-06-03

REPOSE-XLâ„ 

Axogen Corporation

Phase NA Active not recruiting
15 enrolled

Nervous System Diseases, Neuralgia, Neuroma, Peripheral Nervous System Diseases, Trauma, Nervous System, Peripheral Nerve Injuries

NCT04662320 2024-12-05

PHONES

Checkpoint Surgical Inc.

Phase NA Active not recruiting
100 enrolled

Neuroma, Ulnar Neuropathies, Cubital Tunnel Syndrome

NCT02528266 2018-06-13

Surgical Treatment of Symptomatic Neuroma "Stop Neuroma"

Polyganics BV

Phase NA Completed
10 enrolled

Neuroma

NCT01019824 2017-09-15

Efficacy and Safety of Ralfinamide in Patients With Chronic Neuropathic Low Back Pain

Newron Pharmaceuticals SPA

Phase 3 Completed
411 enrolled

Neuroma, Pain

NCT00266214 2011-06-14

Safety and Efficacy of Lidoderm (Lidocaine Patch 5%) in Treating Moderate to Severe Pain Associated With Carpal Tunnel Syndrome

Endo Pharmaceuticals

Phase 3 Terminated
210 enrolled

Carpal Tunnel Syndrome, Neuroma, Pain

NCT00130962 2005-10-03

ALGRX 4975 in the Treatment of Patients With Morton's Neuroma

AlgoRx Pharmaceuticals

Phase 2 Completed
60 enrolled

Morton Neuroma, Neuroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡